Efficacy Evaluation of Bevacizumab Combined with Capecitabine in the Treatment of HER2-Negative Metastatic Breast Cancer: A Meta-Analysis

OBJECTIVE: This study aims to evaluate the efficacy of bevacizumab combined with capecitabine in treating HER2-negative metastatic breast cancer through meta-analysis. METHODS: We searched literature from databases, including PubMed, Web of Science, Wiley Online Library, Ovid, CNKI, and Wanfang data...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yiyi, Chen, Peizhen, Xiang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931458/
https://www.ncbi.nlm.nih.gov/pubmed/36816360
http://dx.doi.org/10.1155/2023/8740221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931458/
https://www.ncbi.nlm.nih.gov/pubmed/36816360
http://dx.doi.org/10.1155/2023/8740221

Ejemplares similares